6-PROPENYLOXO_ZALEPLON;IMPURITY_VII;N-[3-(3-CYANO-6-[(E)-3-((N-ETHYL-N-ACETYL)-AMINO)-PHENYL-3-OXOPROP-1-ENYL]-PYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYL
Compound with spectra: 1 NMR
![6-PROPENYLOXO_ZALEPLON;IMPURITY_VII;N-[3-(3-CYANO-6-[(E)-3-((N-ETHYL-N-ACETYL)-AMINO)-PHENYL-3-OXOPROP-1-ENYL]-PYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYL](/api/compound/BQsIO7KK4Jb.png?ph=true&h=300&w=458 "6-PROPENYLOXO_ZALEPLON;IMPURITY_VII;N-[3-(3-CYANO-6-[(E)-3-((N-ETHYL-N-ACETYL)-AMINO)-PHENYL-3-OXOPROP-1-ENYL]-PYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYL")
| SpectraBase Compound ID | BQsIO7KK4Jb |
|---|---|
| InChI | InChI=1S/C30H28N6O3/c1-5-34(20(3)37)26-11-7-9-22(15-26)28(39)14-13-24-18-32-30-25(17-31)19-33-36(30)29(24)23-10-8-12-27(16-23)35(6-2)21(4)38/h7-16,18-19H,5-6H2,1-4H3/b14-13+ |
| InChIKey | GYJHURKJXXSKIK-BUHFOSPRSA-N |
| Mol Weight | 520.59 g/mol |
| Molecular Formula | C30H28N6O3 |
| Exact Mass | 520.222289 g/mol |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
7-TETRAFLUOROPHENYL-6-ETHOXYCARBONYLPYRAZOLO-[1,5-A]-PYRIMIDINE
Indole-3-carboxylic acid, 5-hydroxy-2-(4-morpholylmethyl)-1-phenyl-, ethyl ester
7-Phenyl-2-(phenylamino)-N-(4-phenylthiazol-2-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
2-BETA,4-BETA-DIBROMO-5-BETA-CHOLESTAN-3-ONE
2-(4-HYDROXYMETHYL-1,3,4,5-TETRAHYDROXY-2-PIPERIDINYL)-2-[(O-TERT.-BUTYLCARBONYL)-TYROSYLAMINO]-ACETIC-ACID-N-BUTYLESTER-P-TOLUENESULFONATE-SALT
2-[(E)-2-(1-benzyl-1H-indol-3-yl)ethenyl]-3-(3-methoxyphenyl)-4(3H)-quinazolinone
METHYL-Z-1-CARBOMETHOXY-2-HYDROXY-5-NITRO-3-INDOLINYLIDENECYANOACETATE
N-Amino-N'-(2,5-di-tert-butylphenyl)perylene-3,4:9,10-tetracarboxylic bisimide
2-TERT.-BUTYL-1,3-DIOXO-6H-1,2,3,5,11,11A-HEXAHYDROIMIDAZO-[1,5-B]-BETA-CARBOLINE
fluorescein, dipotassium salt
| Title | Journal or Book | Year |
|---|---|---|
| Impurity profile study of zaleplon | Journal of Pharmaceutical and Biomedical Analysis | 2007 |